Don’t worry about the sticky – the few that will value the content will find it.
....
Worst advice I have ever seen. But it’s typical of the fight, fight, fight forum culture.
....
In the process of reviewing SRX trade.I’ve done a little more thinking on this rebalancing issue. Please critique, because I am not sure I have got it right and its hard to see the trees for the forest inside my own thoughts.
The decision (or lack of decision) to date has been to let the profits run. I have now decided to limit the mark to market exposure to 25% of an account. If it goes above I will trim it back to just under.
MTU was one of the companies that had climbed in % and it has had a fair impact on my final decision. One morning I looked at the screen and seen a little icon in the announcement field. A little icon that meant MTU wanted me to invest a big chuck of money at short notice at a price over 4 times my average cost – It was renounceable and the price held up early allowing options but it gave me a jolt as to the difficulties around this weighting issue.
MTU was trimmed during the rights period and got another haircut yesterday as did MMS. The gut still doesn’t quit feel right selling for weighting issues rather than business performance reasons. Still not a totally settled issue for me – more a work in progress probably awaiting some lessons to be learnt the hard way.
Whilst the SRX investment feels a bit disappointing just at the moment as I seem to be drawn to consider the failure of selling out at the top – which I shouldn’t because even attempting that was not my game, but I like to kick myself anyway.
Exactly the same - why wouldn't I?At least you made money on the investment.....I guess my question to you now is how will you approach similar situations going forward?
Exactly the same - why wouldn't I?
Although I'm not sure I will always want a "to the moon or bust" speculative position in the portfolio. They're entertaining but on the whole I think boring cash flow is probably more profitable long-term unless you get that element of luck your way.
Exactly the same - why wouldn't I?
Although I'm not sure I will always want a "to the moon or bust" speculative position in the portfolio. They're entertaining but on the whole I think boring cash flow is probably more profitable long-term unless you get that element of luck your way.
I don't want to reply for Craft, but just to save a bit of time.. I think he has already added in a strategy which does so. Whilst it has been done in the name of risk management, the 25% rule effectively achieves the effect locking in some profits after a big run. Craft did this on a few occassions with SRX which he documented at the time and which can also be seen in the review post above (the bit about net realised profits)...I am glad you can sit through a 71% decline from the all time high, I certainly could not....I thought you might of added in a strategy to lock in some of your profits when a stock has had such a good run.....
I don't want to reply for Craft, but just to save a bit of time.. I think he has already added in a strategy which does so. Whilst it has been done in the name of risk management, the 25% rule effectively achieves the effect locking in some profits after a big run. Craft did this on a few occassions with SRX which he documented at the time and which can also be seen in the review post above (the bit about net realised profits)...
Obviously if he had brought his portfolio position down to the 25% level at the $41 level then from that point onwards he would have lost whatever was his position at the time a loss of over 71%."Whilst the SRX investment feels a bit disappointing just at the moment as I seem to be drawn to consider the failure of selling out at the top"
Hope – I really hoped the progression free survival in the liver that Sir Spheres gives would translate to an overall survival benefit in a wide population of sufferers – which is what the trials were designed to show. Turns out the cancers they are dealing with are just god awful systemic beasts and at best SIR-Spheres can help some sub-groups but it can’t help everybody. From my understanding my bottom line was that if I had liver cancer I would want SIR-Spheres as quickly as I could get my hands on it. I somewhat have changed that mindset to I would want to immediately consult the best in the field to see if SIR Spheres would benefit my situation. I think I’ll also double down on healthy living and keep hoping I stay lucky because there’s no easy answers out there for these cancers.
So I’m calling this investment to an end – and putting the results on paper because I’m actually not selling out just yet, rather doing what I consider the hardest thing not to stuff up with biases and coming up with another investment thesis - preliminarily the numbers seem to stack up on adopting SRX as a cash flow investment – though a very high risk one and it has some near term targets to jump through as it rights a ship that is somewhat off kilter at the moment.
Neither the moon or bust... I think it landed some where like a low altitude orbit.Finalising the to the moon or bust investment thesis outcome.
Average holding cost $3.706
Sell $11.77
Thanks for the review... I think this may be the only mistake you have made. You hoped that SRX can help more people (which is not a bad thing) but perhaps that clouded your judgement of the risk:reward? Clearly, cancer sufferers also hoped that SRX would work out for them... and from memory you interacted/took their views into account in your research. Did that also influence your judgement? If Sirtex wasn't about life saving cancer treatment, but something else, say a self-funded mining operation + exploration upside, (ignoring commodity cycle for this thought exercise), would you have acted any differently due to different emotions involved? Perhaps you would have sold more when the market priced it with a higher-than-risk-adjusted chance of success? I am fully aware that it's easy for me to make qualitative statements like these in hindsight of the actual trial outcomes.
Fear, greed and hope are often cited as emotions that are detrimental to investing decisions... but when that hope is anchored on something much bigger than money, perhaps it's harder to deal with?
I think this is actually the part that caught lots of people out. SRX even without elevation into first line treatment is still a very worthy business. But the issues with the corporate governance and faltering sales (be it execution and/or competition) were not something I would have expected if I entered with a moon or bust thesis years back.
Neither the moon or bust... I think it landed some where like a low altitude orbit.
Yes I can see that and no doubt he has done very well out of his investment.
I was making a reply based on part of his comment where he says:
Obviously if he had brought his portfolio position down to the 25% level at the $41 level then from that point onwards he would have lost whatever was his position at the time a loss of over 71%.
It seems to me that he has managed his risk and taking profits accordingly on the way up but not so on the way down.......This seems to be a common theme that I see on ASF...IMHO...eg AKP,SGH to name just two....
Triathlete
I put up some numbers that help understand my SRX outcome without specifying the exact dollar amount.
To make more sense of the numbers you need to assume a quantity of shares – let’s take 100,000.
Average purchase cost: $370,600
Theoretical Sell: $11.77 = $1,177,000
Un-realised capital gain: = $806,400
Dividend Income (44%) = $163,064
Previous Realised Profit from portfolio limit rules (177%) = $655,962
Profit on $370,600 investment: $1,625,426 - 438% over a decade.
That result is O.K but not great considering how long the money was invested for and what it could have been if the trials were an unmitigated success – it works out to something in the range of 15% CAGR.
I’m not going to deny to myself or anybody else the bit you highlight, a 71% drawdown hurts. Its very easy to think of what other meaningful things you could have done with the money that has evaporated.
SRX reached $41.33 at that price the mark to market valuation of 100,000 shares is $4,133,000 and I was hitting portfolio limits so my exposure was 25% of the portfolio.
Mark to Market drawdown = $ 2,956,000 which is nearly twice my actual outcome. If the remainder of my portfolio stands still it is a 18% (71% *25%) drawdown in the portfolio.
But here’s the thing – Yes it hurts but I’m not going to change what I do because it hurts. That immediate profit obsession and avoiding volatility at all costs is the game that everybody else plays because it’s emotionally easy – but it’s not a game that I think makes you rich over the long run.
SRX’s blue sky of uniform first line treatment didn’t work out. Sometimes investments don’t work out – that is risk – that is what we do, we bear the risk. But it could have worked out and I had a plan that allowed me to be exposed at full clip to the high-risk events. That’s what I wanted – I didn’t want to avoid them.
It’s easy to say they should have been avoided in hindsight – But I have yet to meet a rich hindsight warrior. And I don’t know of any other more pro-active risk management method (especially at size) that would have not cut you to pieces on the SRX gaps.
If I want to avoid 71% (or higher) drawdowns for emotional reasons, I will avoid making these types of investments altogether but I wouldn’t change how I execute the plan If I do take one again.
I think there will be room for other similar speculative positions in the portfolio and in my emotion bank again in the future - despite the potential drawdowns.
You have a plan and you stick to it.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?